doi: 10.3390/v13040677 65 SabettaW.ParadisoA.PaciollaC.de PintoM
Existing literature consists primarily of level IV and level V evidence
hence establishing the link between preclinical mechanistic knowledge and clinical decision-making (238)
Biologic therapies that target specific disease mediators have become a mainstay in the treatment of moderate-to-severe disease, whereas advances in the treatment of mild-to-moderate disease have been limited
Supplement interactions with proton pump inhibitor (PPI) drugs like omeprazole (Prilosec) and Nexium
1419, named BPC 157, which is a part of the sequence of human gastric juice protein, coded BPC, freely soluble in water at pH 7.0 and in saline, was prepared (Diagen, Ljubljana, Slovenia) as described before[2-7,34]